CIK 0001856725 · <br>Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 863114789
- Phone
- (408) 457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-16 | IMRAN MIR A Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2024-12-16 | Nanavaty Maulik Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2024-12-16 | Nanavaty Maulik Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2024-12-16 | Nanavaty Maulik Director | Returned to the company · Stock Option (Right to Buy) | −15,423 | 0 | ||
| 2024-12-16 | Nanavaty Maulik Director | Grant or award · Stock Option (Right to Buy) | +15,423 | 79,317 | ||
| 2024-12-13 | McKinley Kate Chief Business Officer | Purchase | +17,960 | $1.67 | $30K | 17,960 |
| 2024-12-09 | Imran Talat Chief Executive Officer | Purchase | +10,296 | $1.94 | $20K | 494,751 |
| 2024-10-15 | South Cone Investments Limited Partnership 10% owner | Sale | −3,305,622 | $2.55 | $8.4M | 8,825,932 |
| 2024-10-15 | South Cone Investments Limited Partnership 10% owner | Sale | −523,738 | $3.26 | $1.7M | 8,302,194 |
| 2024-05-29 | IMRAN MIR A Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-29 | Ausiello Dennis A Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-29 | Farquharson Andrew Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-29 | Nanavaty Maulik Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-29 | DEBUONO LAUREEN Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-29 | Rometty Lisa Ann Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-05-29 | BUTEL JEAN LUC Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2024-03-21 | McKinley Kate Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +323,500 | 323,500 | ||
| 2024-03-21 | Imran Talat Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,085,000 | 1,085,000 | ||
| 2024-03-21 | Groen Eric General Counsel | Grant or award · Stock Option (Right to Buy) | +323,500 | 323,500 | ||
| 2024-03-21 | Hashim Mir Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +323,500 | 323,500 |
Page 4 of 9 · 178 trades